SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-074439
Filing Date
2023-06-26
Accepted
2023-06-26 06:03:44
Documents
13
Period of Report
2023-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319637d1_8k.htm   iXBRL 8-K 29531
2 EXHIBIT 99.1 tm2319637d1_ex99-1.htm EX-99.1 23604
  Complete submission text file 0001104659-23-074439.txt   236137

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA espr-20230624.xsd EX-101.SCH 3227
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20230624_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20230624_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319637d1_8k_htm.xml XML 3619
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 231039338
SIC: 2834 Pharmaceutical Preparations